Wegovy Profitability Will Keep Improving, Novo CEO Says
Share
Novo Nordisk Chief Executive Officer Mike Doustdar says the profitability of its popular Wegovy weight-loss pill is "decent" and will continue to improve. "If that was not the case, we would not be launching the product in more and more markets," he tells Bloomberg Television.
More from Australia
Titanium Sands secures $500,000 Sri Lankan funding
WIN Metals expands Butchers Creek gold tenure package
Forte Energy enters South American oil exploration agreement
Pathkey.AI validates Chipforge platform through independent testing
Arovella Therapeutics names acting CEO
Ingenia Communities rejects new Warburg Pincus buyback offer